Vaccines, Blood & Biologics

CBER Secure Email Policy Takes Effect October 1, 2018

In an effort to streamline and facilitate communication with sponsors and protect proprietary and company confidential information, CBER will increase the use of secure email for regulatory communications. Therefore, CBER’s outgoing email communications that contain regulatory information will occur only with recipients who have a secure email account with FDA. Communication that is not regulatory in nature, such as logistics on how to get to the White Oak Campus, or general information that does not relate to regulatory information may be sent by unsecure email.

Additional resources to help you to easily set up secure email are available. If you don’t already have secure email or have any related questions, please contact us at SecureEmail@fda.hhs.gov for further information. Please allow time, approximately a week, to establish an account. CBER will continue to communicate by hard copy letters sent through the U.S. Postal Service with those who do not have a secure email account.

On September 26, 2018, CBER hosted a webinar to discuss and answer questions about how to set up FDA secure email. 

If you have any questions, please contact the Office of Information Management and Technology (OIMT) at SecureEmail@fda.hhs.gov.

Webinar Materials

Presentation

 

Page Last Updated: 10/05/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English